Recruiting
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
NCT07617285
- Conditions
- AML, Refractory/Relapse Acute Myeloid Leukemia
- Locations
-
- Peking University People's Hospital Beijing, China
Clinical trial condition
Refractory/Relapse Acute Myeloid Leukemia
Explore clinical trials studying Refractory/Relapse Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.
2 public trials
2 recruiting studies
Refractory/Relapse Acute Myeloid Leukemia trial results
Recruiting
Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT04716452
- Conditions
- Acute Myeloid Leukemia, Refractory, Acute Myeloid Leukemia, in Relapse, Disease Attributes, +11 more
- Locations
-
- University of Virginia Cancer Center Charlottesville, Virginia, United States